4
Changes in Ownership
ORAMED PHARMACEUTICALS INC. Filed Acc 0001178913-15-000942
President and CEO bought 2,600 shares at an average $3.88 ($10,082)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| KIDRON NADAV President and CEO | 2015-03-18 | Purchase | +500 | $3.78 | $1,890 | 954,448 | D: show line 1 in the form |
| KIDRON NADAV President and CEO | 2015-03-18 | Purchase | +500 | $3.80 | $1,900 | 954,948 | D: show line 2 in the form |
| KIDRON NADAV President and CEO | 2015-03-19 | Purchase | +400 | $3.95 | $1,580 | 955,348 | D: show line 3 in the form |
| KIDRON NADAV President and CEO | 2015-03-19 | Purchase | +1,100 | $3.92 | $4,312 | 956,448 | D: show line 4 in the form |
| KIDRON NADAV President and CEO | 2015-03-19 | Purchase | +100 | $4.00 | $400 | 956,548 | D: show line 5 in the form |
| Open-market purchases · 2,600 sh · avg $3.88 · $10,082 | |||||||
Loading xslF345X03/zk1516648.xml…